Why is Indrayani Biotec falling/rising?

As of 16-Jul, Indrayani Biotech Ltd's stock price is currently at 14.07, reflecting an increase of 0.12 or 0.86%. The stock has shown a trend reversal by gaining after two consecutive days of decline. However, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally weak performance. Over the past week, the stock has decreased by 9.23%, and it has significantly underperformed with a year-to-date return of -61.32%. The company's financial health is concerning, as it has reported operating losses and a high Debt to EBITDA ratio of 9.25 times, which indicates a low ability to service its debt. Additionally, the stock has generated a return of -73.55% over the past year, with profits falling by 134.9%, contributing to a negative sentiment among investors.
In the broader market context, the Sensex has shown a slight decline of 1.08% over the past week, which is less severe than the stock's performance. This suggests that while the market is experiencing some downturn, Indrayani Biotech's struggles are more pronounced. Institutional investors have reduced their stake in the company by 1.59%, reflecting a lack of confidence in its long-term fundamentals. The stock's liquidity remains adequate for trading, but the falling delivery volume indicates diminishing investor interest. Overall, the combination of poor financial results, declining institutional participation, and significant underperformance relative to the benchmark has contributed to the stock's recent movement.